Literature DB >> 3018593

Changes in central alpha-adrenoceptors and noradrenaline content after high sodium intake in Sabra salt-sensitive and salt-resistant rats.

A Parini, L Diop, D Laude, D Ben-Ishay, J P Dausse.   

Abstract

Several studies have suggested a correlation between sodium accumulation and the development of hypertension. However, the mechanisms whereby sodium is able to increase blood pressure remain unclear. In the present study, alpha-adrenoceptors and noradrenaline contents have been studied in the cerebral cortex, hypothalamus and medulla oblongata in the Sabra rat strain in order to define their role in the resistance or sensitivity to sodium-induced hypertension. Alpha-Adrenoceptors were defined using the selective ligands 3H-prazosin and 3H-rauwolscine for alpha 1- and alpha 2-adrenoceptors, respectively. Under normal sodium diet, alpha 2-adrenoceptor density was higher in cerebral cortex and lower in hypothalamus and medulla oblongata of SBN (salt-resistant) compared to SBH (salt-sensitive) rats. Five weeks of high sodium intake induced a decrease in alpha 2-adrenoceptor density in cerebral cortex and an increase in hypothalamus only in SBN rats. These changes abolished the differences between SBH and SBN rats observed with a normal sodium diet. No changes in density and affinity of alpha 2-adrenoceptors were observed in medulla oblongata of SBN and SBH rats. Density and affinity of alpha 1-adrenoceptors were similar in SBN and SBH rats in all the tissues studied and they were unaffected by the high sodium diet. Noradrenaline contents in cerebral cortex, hypothalamus and medulla oblongata were also similar in the two rat substrains under normal sodium diet, but high sodium intake induced a decrease cerebrocortical noradrenaline content only in SBN rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018593     DOI: 10.1007/bf00506513

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Serum 5-nucleotidase.

Authors:  T F DIXON; M PURDOM
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

3.  Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients.

Authors:  D M WATKIN; H G FROEB; F T HATCH; A B GUTMAN
Journal:  Am J Med       Date:  1950-10       Impact factor: 4.965

4.  Sodium chloride preference in hypertensive (H) and normotensive (N) rats.

Authors:  D Ben-Ishay; S Dikstein; B Shalita
Journal:  Pflugers Arch       Date:  1976-01-30       Impact factor: 3.657

5.  Adrenoceptor of the alpha 2-subtype mediating inhibition of the human fat cell adenylate cyclase.

Authors:  H Kather; B Simon
Journal:  Eur J Clin Invest       Date:  1981-04       Impact factor: 4.686

6.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

Authors:  H A Feldman
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

7.  Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine.

Authors:  A Takeshita; A L Mark; M J Brody
Journal:  Am J Physiol       Date:  1979-01

8.  Catecholamines and vasopressin in forebrain nuclei of hypertension prone and resistant rats.

Authors:  G Feuerstein; R L Zerbe; D Ben-Ishay; I J Kopin; D M Jacobowitz
Journal:  Brain Res Bull       Date:  1981-12       Impact factor: 4.077

9.  Experimental hypertension and catecholamine distribution in the rat brain.

Authors:  N Zamir; Y Gutman; D Ben-Ishay
Journal:  Brain Res       Date:  1979-07-27       Impact factor: 3.252

10.  Differential development of salt-induced and renal hypertension in Dahl hypertension-sensitive rats after neonatal sympathectomy.

Authors:  R Friedman; L M Tassinari; M Heine; J Iwai
Journal:  Clin Exp Hypertens       Date:  1979       Impact factor: 1.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.